An important event in the development of the germline is the initiation of meiotic development. In Caenorhabditis elegans, the conserved GLP-1/Notch signaling pathway regulates the proliferative versus meiotic entry decision, at least in part, by spatially inhibiting genes in the gld-1 and gld-2 parallel pathways, which are proposed to either inhibit proliferation and/or promote meiotic development. Mutations that cause constitutive activation of the GLP-1 pathway, or inactivation of both the gld-1 and gld-2 parallel pathways, result in a tumorous germline in which all cells are thought to be proliferative. Here, to analyze proliferation and meiotic entry in wild-type and mutant tumorous germlines, we use anti-REC-8 and anti-HIM-3 specific antibodies as markers, which under our fixation conditions, stain proliferative and meiotic cells, respectively. Using these makers in wild-type animals, we find that the border of the switch from proliferation to meiotic entry is staggered in late-larval and adult germlines. In wild-type adults, the switch occurs between 19 and 26 cell diameters from the distal end, on average. Our analysis of mutants reveals that tumorous germlines that form when GLP-1 is constitutively active are completely proliferative, while tumors due to inactivation of the gld-1 and gld-2 pathways show evidence of meiotic entry. Genetic and time course studies suggest that a third pathway may exist, parallel to the GLD-1 and GLD-2 pathways, that promotes meiotic development.
Introduction
Germline proliferation, meiosis, and gametogenesis are essential processes for the continued existence of sexually reproducing species. A key step in the development of the germline and the production of gametes is the decision of germ cells to either proliferate or undergo meiotic development. Germline proliferation is essential, first to amplify the germline before the initial onset of meiosis, and then to maintain the germline stem cells so that gametes can be produced continuously in the reproductive adult. Meiosis is essential since it is the means by which a diploid organism makes haploid gametes, which then combine with other haploid gametes to generate diploid offspring. Germ cells that enter meiotic prophase must produce all of the cellular components necessary for meiosis to occur properly, such as factors that align homologous chromosomes and form the synaptonemal complex, factors involved in reciprocal meiotic recombination, as well as factors that properly segregate the homologous chromosomes to opposite poles (Champion and Hawley, 2002) . These cells also must synthesize the components necessary for differentiation into gametes.
Much of our current knowledge of the factors involved in regulating meiotic entry in animals has been obtained through genetic analysis of model organisms such as Caenorhabditis elegans and Drosophila. In C. elegans, the adult hermaphrodite germline is spatially patterned with a proliferative stem cell population in the most distal end of the gonad (Fig. 1 ). Most cells in the germline are syncytial, but with each nucleus partially enclosed by a plasma membrane. We refer to each nucleus and its surrounding cytoplasm and membranes as a germ cell. As cells move proximally away from the distal tip, they enter meiotic prophase. Genetic and molecular analysis implicates the conserved GLP-1/Notch signaling pathway as the major controller of the proliferation versus meiosis decision (Seydoux and Schedl, 2001) . Spatially controlled activation of the pathway occurs when membrane-bound LAG-2 ligand (Henderson et al., 1994; Tax et al., 1994) , expressed in the somatic distal tip cell (DTC) (Fitzgerald and Greenwald, 1995; Henderson et al., 1994) , binds to the GLP-1 receptor (Austin and Kimble, 1987; Yochem and Greenwald, 1989) , which is expressed in the germ cells (Crittenden et al., 1994) . Ligand binding is thought to cause the intracellular portion of GLP-1 to translocate to the nucleus of the germ cells and bind the LAG-1 transcription factor, thereby causing the transcription of Fig. 1 . The proliferation versus meiotic development decision in the C. elegans germline. (A) Drawing of a wild-type adult hermaphrodite (top) and a blow-up of one of the gonad arms (bottom). The somatic distal tip cell (DTC) caps the very distal end of the gonad. Proliferative or mitotic germ cells (green) begin meiotic development as they move proximally and enter the transition zone, which corresponds to leptotene/zygotene (Dernburg et al., 1998) . Cells continue to progress through meiotic prophase (red) as they move proximally, eventually differentiating as first sperm (blue), then oocytes (yellow). Cells in the gonad are syncytial, sharing a common cytoplasm, but cellularize as sperm and oocytes. For convenience of illustration, the arrangement of the gonad arms relative to the intestine are not depicted accurately. (B) Dissected gonad arms of a wild-type adult hermaphrodite (top) and glp-1(gf) mutant (bottom) with a tumorous germline, both stained with DAPI to visualize nuclear morphology. Distal is to the left. Actual genotype of glp-1(gf) mutant is dpy-19(e1259) unc-32(e189) glp-1(oz112gf)/dpy-19(e1259) unc-32(e189) glp-1(oz112gf); qDp3 (qDp3 contains unc-32(e189) and wild-type copies of dpy-19 and glp-1; Austin and Kimble, 1987) . Scale bar = 20 Am. (C) Genetic pathway involved in regulating the proliferation versus meiotic entry decision. In this model, GLP-1/Notch signaling, consisting of lag-2, glp-1, and lag-1, inhibits the activities of the gld-1 and gld-2 pathways. These two pathways function redundantly to promote meiotic development and/or inhibit proliferation. Adapted from Kadyk and Kimble (1998) and Hansen et al. (2004). target genes (Mumm and Kopan, 2000) . If the GLP-1 signaling pathway is rendered inactive, all germ cells enter meiosis, depleting the stem cell population (Austin and Kimble, 1987; Lambie and Kimble, 1991) . Conversely, in glp-1(oz112gf) gain-of-function mutants, in which the GLP-1 receptor is constitutively active, germ cells fail to enter meiosis, continue to proliferate, and form a germline tumor in which all cells appear to be proliferative, as indicated by nuclear morphology (Berry et al., 1997) . In glp-1(oz112gf) hemizygotes or in animals carrying the weaker glp-1(ar202gf) mutation, the proliferation versus meiotic development decision in the distal germline is initially normal; however, the size of the proliferative zone increases in the adult over time, with germ cells entering meiosis progressively much further from the DTC (Berry et al., 1997; Pepper et al., 2003a) . This over-proliferation phenotype is called a 'late-onset' tumor.
While the tumors described above appear to be due to a defect in meiotic entry, some other tumors are not due to a meiotic entry defect, even though superficially they look similar to glp-1(oz112gf) tumors. For example, hermaphrodites mutant for gld-1, which encodes a KH domain translational inhibitor (Jan et al., 1999; Jones and Schedl, 1995; Lee and Schedl, 2001) , have a germline tumor that is due to a failure of female germ cells to successfully progress through meiotic prophase (Francis et al., 1995a,b) . Careful analysis of the germ cells in these animals throughout development has shown that they enter meiosis at the normal stage of development and the correct location in the gonad, but they are unable to complete meiotic prophase. Instead, female pachytene stage germ cells re-enter the mitotic cell cycle and proliferate forming a large germline tumor. Similarly, during spermatogenesis of Pumilio puf-8 mutants, primary spermatocytes dedifferentiate back into mitotically dividing cells, forming a proximal germline tumor (Subramaniam and Seydoux, 2003) . Thus, both gld-1 and puf-8 mutants demonstrate that ectopic germline over-proliferation is not always due to a defect in meiotic entry, but that defects in meiotic progression can also cause this general phenotype.
The GLP-1/Notch signaling pathway promotes proliferation and/or inhibits meiotic development. Loss of all of the activities that work in the opposite direction (promote meiotic development and/or inhibit proliferation) is predicted to result in a tumor that is identical to constitutive activation of glp-1 (glp-1(oz112gf); Berry et al., 1997) . GLP-1 signaling has been proposed to inhibit the activities of two genetically downstream genes, gld-1 and gld-2, which each either inhibit proliferation and or promote meiotic entry (Francis et al., 1995b; Kadyk and Kimble, 1998) . The role of gld-1 in the proliferation versus meiotic development decision described here is different from its role in female meiotic prophase progression described above. For meiotic entry, gld-1 is proposed to function redundantly with gld-2 (Kadyk and Kimble, 1998), which encodes a catalytic subunit of a poly(A) RNA polymerase (Wang et al., 2002) . In gld-1 or gld-2 single null mutants, germ cells enter meiosis normally (Francis et al., 1995a; Kadyk and Kimble, 1998) . When the activities of both gld-1 and gld-2 are absent, a tumorous germline forms independent of germline sex (Kadyk and Kimble, 1998) as indicated by increased cell numbers, ectopic proliferation [based on phospho-histone (H3) staining, a mitotic Mphase marker], and a lack of meiotic entry based on nuclear morphology as revealed by DAPI staining. Therefore, the tumors in gld-1 and gld-2 mutants are thought to result from disruption of the decision to enter meiotic prophase based on nuclear morphology (Kadyk and Kimble, 1998) . Because gld-1 and gld-2 are redundant in this meiotic entry function, we refer to the tumor formed in gld-2 gld-1 double null mutant animals as a synthetic tumor. A similar synthetic tumorous phenotype is seen when the activities of both nos-3 and gld-2 are eliminated (Hansen et al., 2004) . NOS-3 is one of three C. elegans genes similar to Drosophila Nanos (Kraemer et al., 1999; Subramaniam and Seydoux, 1999) , and is proposed to function in the gld-1 pathway for regulating meiotic entry (Hansen et al., 2004) .
DNA morphology, as visualized by DAPI staining, has been the primary means by which meiotic entry has been studied in wild-type and tumorous germlines in C. elegans. While certain stages of both mitosis and meiosis are easily recognizable by DAPI-stained DNA morphology, and while this remains a convenient means to assess germline nuclear morphology, the earliest stages of meiotic prophase (leptotene/zygotene) are not always easily distinguishable from neighboring proliferating cells, making it difficult to accurately study meiotic entry. Moreover, these difficulties are magnified in mutants where the positions and borders between these cell populations are abnormal.
Here we use two markers, one proliferation-specific and the other meiotic-specific, to more precisely study the proliferation versus meiotic entry decision in C. elegans. In wild-type late-larval and adult animals, we find that meiotic entry is spatially variable with respect to distance from the DTC, resulting in a segment of the germline that contains both proliferating and meiotic cells. We also use these markers to analyze germline tumors thought to result from disruption of the proliferation versus meiotic entry decision. We find that the glp-1(oz112gf) tumor is completely proliferative; however, cells within the gld-2 gld-1 and gld-2; nos-3 null mutant synthetic tumors show evidence of meiotic entry and thus are not completely proliferative. Therefore, the synthetic tumors are not equivalent to the canonical glp-1(gf) tumor. We further show by genetic analysis and time course experiments that GLD-1, GLD-2, and NOS-3 function in regulating meiotic entry. We propose that at least one additional pathway exists, parallel to the gld-1 and gld-2 pathways, to regulate the proliferation versus meiotic entry decision.
Materials and methods

Nematode strains and culture
Standard procedures for culture and genetic manipulation of C. elegans strains were followed with growth at 20j unless otherwise noted (Sulston and Hodgkin, 1988) . Descriptions of genes, alleles, and phenotypes related to this study are in Hodgkin and Martinelli (1999) .
The following mutations were used:
LGI: gld-2 (q497null) (Kadyk and Kimble, 1998) , gld-1(q485null) (Francis et al., 1995a) , gld-1(q361) (Francis et al., 1995a) ;
LGII: dpy-10(e128), nos-2(ok230) (probable null) (generated by the C. elegans Gene Knockout Consortium), nos-1(gv5) (probable null) (Subramaniam and Seydoux, 1999) , nos-3(oz231null) (Hansen et al., 2004) , unc-4(e120), sqt-1(sc13); LGIII: unc-36(e251), dpy-19(e1259), unc-32(e189), glp-1(q175null) (Austin and Kimble, 1987) , glp-1(oz112gf) (Berry et al., 1997) , glp-1(ar202gf) (Pepper et al., 2003a) , glp-1(q172) (Austin and Kimble, 1987) . The nos-2(ok230) allele is due to deletion of bases 30 999 -33 076 of cosmid ZK1127 (GenBank accession , U58758) and also deletes a portion of the him-14 gene (K. Subramaniam and G. Seydoux, personal communication) .
The nos-2(ok230) nos-3(oz231) nos-1(gv5) triple mutant chromosome was constructed by first constructing a nos-3(oz231) nos-1(gv5) chromosome. This was accomplished by crossing nos-3(oz231) sqt-1(sc13)/unc-4(e120) nos-1(gv5) heterozygous males with unc-4(e120) sqt-1(sc13) hermaphrodites and picking the non-Unc, non-Sqt recombinants. nos-2(ok230) was recombined onto this chromosome by crossing dpy-10(e128) nos-3(oz231) nos-1(gv5)/nos-2(ok230) unc-4(e120) heterozygous males with dpy-10(e128) unc-4(e120) hermaphrodites and picking nonDpy non-Unc hermaphrodites. The presence of the mutations for each of the three nos genes on the resulting chromosome was confirmed by PCR analysis.
Antibody staining
Antibody staining of dissected gonads is described (Jones et al., 1996) . As determined by immunohistochemical detection, REC-8 protein is found in the nucleoplasm and on the DNA of germ cells in the mitotic zone, in short threads in transition zone cells (corresponding to axial elements of the chromosomes), and long threads in pachytene cells (lateral elements of the meiotic chromosomes; Pasierbek et al., 2001) . We see this same pattern using similar fixation conditions (formaldehyde, ethanol, methanol, and acetone) to those previously described (Pasierbek et al., 2001 ). However, this method leads to a low yield of intact gonads using our batch method (Jones et al., 1996) , as well as spurious membrane staining. Instead, our conditions were as follows: dissected gonads were fixed in 3% formaldehyde/0.1 M K 2 HPO 4 (pH 7.2) for 1 h at RT followed by 5-min incubation with 100% MeOH at À 20jC. Under these conditions, anti-REC-8 antibody staining was detected in the nucleoplasm and on the DNA of germ cells within the mitotic zone, but was not observed in meiotic prophase chromosomes, presumably because these more interior epitopes were not exposed in the absence of the acetone extraction step. Fluorescent images were captured with a Zeiss Axioskop microscope equipped with Hamamatsu digital CCD camera (Hamamatsu Photonics). Anti-HIM-3 antibodies were kindly provided by Monique Zetka (Zetka et al., 1999) and anti-REC-8 antibodies were generously provided by Pavel Pasierbek and Joseph Loidl (Pasierbek et al., 2001 ).
Time course analyses
To obtain many synchronized animals, adult hermaphrodites were treated with hypochlorite solution and their eggs were isolated (Sulston and Hodgkin, 1988) . The eggs were then suspended in M9 buffer and shaken at 20jC to arrest animals in the L1 stage. Arrested animals were washed with M9 buffer and placed on standard NGM plates (Sulston and Hodgkin, 1988) and grown for specific lengths of time at 20jC (unless otherwise noted), then dissected and stained as described above.
Results
Anti-REC-8 and anti-HIM-3 antibodies serve as mutually exclusive markers for meiotic entry under certain fixation conditions The C. elegans germline is a useful system for studying germline development, partially due to the spatial organization of the gonad (Hubbard and Greenstein, 2000) . Simple DAPI staining of dissected gonads to visualize nuclear morphology reveals the general spatial organization (Fig. 1B) . At the region where germ cells first show evidence of entering meiotic prophase, roughly 20 cells diameters from the distal end of the adult gonad where the DTC resides (Crittenden et al., 1994) , DAPI staining in nuclei of cells in the leptotene/zygotene stages of meiotic prophase takes on a crescent-shaped appearance (we will refer as cells with crescent-shaped nuclei) (MacQueen and Villeneuve, 2001) . Although this change in DAPI nuclear morphology is useful for identifying cells that have entered meiotic prophase, it is somewhat subjective. Antibodies that specifically recognize HIM-3, a component of the proteinaceous core that exists between sister chromatids (Zetka et al., 1999) , have also been useful for identifying meiotic cells (MacQueen and Villeneuve, 2001; Zetka et al., 1999) . To thoroughly study the proliferation versus meiotic entry decision, a marker specific for proliferative germ cells would also be valuable. Antibodies specific to phospho-histone (H3) identify a small subset of proliferative germ cells, those in late prophase and early mitotic Mphase (Ajiro et al., 1996) . Therefore, the majority of proliferative cells (those in late M, interphase, and S phase) is not marked.
We found that under certain fixation conditions, REC-8-specific antibodies serve as a useful marker for specifically identifying proliferative germ cells, and in combination with HIM-3 antibodies, can distinguish proliferative from early-meiotic prophase germ cells. REC-8 is part of the sister-chromatid cohesion protein family and is found in the nucleoplasm and on the DNA of cells in the proliferative zone, as well as in the proteinaceous core of sister chromatids in meiotic prophase (Pasierbek et al., 2001) . Using relatively mild fixation conditions, we only observed the nucleoplasmic and the non-proteinaceous core chromosomal staining in the proliferative zone (see Materials and methods).
To determine the specificity of anti-REC-8 antibodies for proliferative germ cells, and the usefulness of the combination of anti-REC-8 and anti-HIM-3 antibodies in studying the proliferation versus meiotic entry decision, we analyzed anti-REC-8 and anti-HIM-3 staining patterns relative to (1) each other, (2) transition zone (crescent-shaped DAPI staining) nuclei, and (3) Scherthan, 1997; Zickler and Kleckner, 1999) . These results demonstrate that under mild fixation conditions, REC-8 and HIM-3 distinguish proliferative and early meiotic germ cells and thus provide a useful tool in studying the proliferation versus meiotic entry decision.
Meiotic entry in wild-type hermaphrodites
To better characterize meiotic entry during development (from L2 to young adult), we examined REC-8 and HIM-3 staining patterns in synchronous staged populations of wildtype animals (see Materials and methods). We first observed HIM-3-positive/REC-8-negative cells in the proximal end of the early L3 germline, 32 h past L1 arrest, at a time when the germline measures approximately 13 cell diameters from the distal end (Fig. 4) . The length of the proliferative zone continues to increase and reaches maximum distance (as measured by cell-diameter-lengths) between late L4 and young adult (44 -50 h past L1 arrest). During the L3 and early L4 stages, the length of the proliferative zone increases, and the transition between mitosis and meiosis occurs over a distance of one cell diameter. Thus, during early stages, the switch from proliferation to meiotic entry occurs across a sharp border of REC-8-positive to HIM-3-positive cells at a given distance from the distal tip.
By the late L4 stage, 44 h past L1 arrest, a region becomes evident that contains both proliferative (REC-8-positive/HIM-3-negative) and meiotic (REC-8-negative/ . The region shown is part of the meiotic entry region with the arrow pointing to a representative transition zone nucleus with crescent-shaped DAPI staining. The asterisk is beside a REC-8-positive nucleus that has a non-crescent-shaped DNA organization but is further from the DTC than the HIM-3-positive nucleus with crescent-shaped DAPI staining (arrow). This and other REC-8-positive nuclei in the meiotic entry region are more yellow than in the proliferative region, which appears to be due to faint HIM-3 staining and may represent cells that are in the transition from REC-8-positive to HIM-3-positive. Scale bars = 20 Am.
HIM-3-positive) cells at the same distance from the distal end (Fig. 4) . Adult males show a similar pattern of nonuniform meiotic entry (data not shown). Thus, at this stage, the distal germline can be separated into three distinct regions. The first (closest to the DTC) region consists of only proliferative cells. In adults (1 day past L4) it extends approximately 19 cell diameters from the DTC and all cells are REC-8-positive HIM-3-negative (Fig. 2) . It should be noted that cells in the more distal half of this region often show a lower level of REC-8 expression than the more proximal half, suggesting that the proliferative zone may not be a homogeneous population (Fig. 3) . The second region consists of both proliferative and early meiotic prophase cells equidistant from the DTC. We refer to this region as the 'meiotic entry region'. Specifically, we define this region as the segment between the HIM-3-positive cell For each time point, a total of 12 gonad arms were analyzed, except for at 32 h. This time point was divided into two based on whether the arms only contained proliferative cells (left, N = 10), or both proliferative and meiotic cells (right, N = 6). For the 50-h time point, no maximum distance was measured because these animals contained sperm in the proximal end of the gonad making the cell diameter measurement of distance from the distal end inaccurate. Error bars = 1 SD.
closest to the DTC and the REC-8-positive cell furthest from the DTC (Figs. 2B and 3 ). This meiotic entry region averages seven cell diameters, though it varies from animal to animal (Figs. 2B and 3 ). For example, among the 15 gonad arms analyzed in Fig. 2B , the closest HIM-3-positive nucleus to the DTC was 14 cell diameters away, while the furthest REC-8-positive nucleus from the DTC was 32 cell diameters away (as measured in different gonad arms). The late larval/adult meiotic entry region should not be confused with the transition zone, which is much larger. Our working definition of the transition zone is that it constitutes the region between the cells closest to the DTC and those furthest from the DTC that have a crescent-shaped DNA organization (this definition is similar though not identical to that described previously; Crittenden et al., 1994) . While the distal portion of the transition zone consists of both REC-8-positive and HIM-3-positive cells, the proximal portion contains only HIM-3-positive cells, and therefore would not be considered part of the late larval/adult meiotic entry region ( Figs. 2A and 3) . The third region consists of only meiotic (REC-8-negative/HIM-3-positive) cells, and encompasses all cells proximal to the REC-8-positive cell furthest from the DTC. Therefore, the late larval/adult gonad consists of both proliferative and meiotic cells spatially separated, with a staggered border between the two populations (Figs. 2 and 3 ).
Meiotic entry occurs in synthetic tumorous mutants
Using the REC-8 (proliferation) and HIM-3 (meiotic prophase) markers, we analyzed various tumorous mutants to determine if the tumors consisted solely of proliferative cells by these more stringent criteria. We first analyzed the canonical strong glp-1(gf) tumor [glp-1(oz112gf)/glp-1(oz112gf)/glp-1(+) at 25jC], in which the GLP-1 receptor is constitutively active (Berry et al., 1997) . The germ cells in adult gonads stained positively for REC-8 throughout the germline, and lacked HIM-3 staining (Fig. 5, Table 1 ), indicating that this germline tumor consists only of proliferating cells with no evidence of meiotic entry. Identical results were observed when larval gonads of this genotype were examined (data not shown).
Surprisingly, synthetic tumorous germlines from gld-2(q497) gld-1(q485) double null adult animals contained not only proliferative cells (REC-8-positive and HIM-3-negative), but also meiotic cells (REC-8-negative and HIM-3-positive) (Fig. 5, Table 1 ). While the number of REC-8-negative/HIM-3-positive cells, and thus the extent of meiotic entry, varied from animal to animal, 92% of gonad arms examined contained meiotic cells (Table 1) .
Synthetic tumorous germlines from gld-2(q497); nos-3(oz231) double null adult animals displayed an even greater extent of meiotic entry than in gld-2(q497) gld-1(q485) animals. All gonad arms examined contained REC-8-negative/HIM-3-positive cells, and the number of meiotic cells was greater than in gld-2(q497) gld-1(q485) animals (Table 1) . nos-3 is one of three related nos proteins in the C. elegans genome that shows similarity to Drosophila Nanos (nos-1, nos-2, and nos-3) (Kraemer et al., 1999; Subramaniam and Seydoux, 1999) . To test if the nos genes function redundantly in regulating meiotic entry, we examined the extent of meiotic entry in gld-2; nos-2 nos-3 nos-1 quadru- Fig. 5 . Proliferating and meiotic cells in germline tumors. Dissected gonad arms stained with DAPI (A, B, and C; blue), REC-8 antibodies (D, E, and F; green), and HIM-3 antibodies (D, E and F; red) with distal to the left. Actual genotypes; (A and D) dpy-19(e1259) unc-32(e189) glp-1(oz112gf)/dpy-19(e1259) unc-32(e189) glp-1(oz112gf); qDp3 (qDp3 contains unc-32(e189) and wild-type copies of dpy-19 and glp-1; Austin and Kimble, 1987) grown at 25jC; (B and E) gld-2(q497) gld-1(q485); unc-32(e189); (C and F) gld-2(q497); nos-3(oz231); unc-32(e189). Scale bar = 20 Am.
ple mutants and found that the extent of meiotic entry was essentially the same as that seen in gld-2; nos-3 double mutants (Table 1) . We conclude that nos-1 and nos-2 likely do not function redundantly with nos-3 in regulating meiotic entry.
Since the glp-1(oz112gf) tumor shows no evidence of meiotic entry while both gld-2 gld-1 and gld-2; nos-3 synthetic tumors contain meiotic cells, the synthetic tumorous mutants are not equivalent to the glp-1(gf) tumor. Therefore, the elimination of gld-1 and gld-2 pathway genes is not equivalent to constitutive activation of the GLP-1/ Notch pathway. Since gametes are not formed in the synthetic tumorous mutants, although cells have entered meiosis, meiotic prophase progression must also be disrupted. gld-1 single mutants are known to have a meiotic progression defect in female germ cells (Francis et al., 1995a) , and gld-2 single mutants have meiotic progression defects in both male and female germ cells (Kadyk and Kimble, 1998) .
The synthetic tumorous phenotype derives from a defect in meiotic entry, rather than meiotic progression Since some cells enter meiosis in gld-2 gld-1 and gld-2; nos-3 double mutant adults, this raises the possibility that these synthetic tumors derive from a defect in meiotic prophase progression rather than meiotic entry, analogous to the etiology of the female germ cell tumorous phenotype in the gld-1 single mutant. As mentioned previously, female germ cells in gld-1 null single mutants enter meiotic prophase; however, the cells fail to progress beyond the pachytene stage, but rather exit meiotic prophase and return to mitosis, resulting in a large germline tumor (Francis et al., 1995a,b) . To determine if the synthetic germline tumors in gld-2(q497) gld-1(q485) and gld-2(q497); nos-3(oz231) animals are due to a defect in the entry into meiosis decision, as in glp-1(gf) mutants, or due to an inability to progress through meiotic prophase, as in the gld-1 single mutant female germ cells, we asked if each single synthetic tumorous mutant could enhance a weak glp-1(gf) allele. We reasoned that null mutations in genes that promote meiotic entry should enhance a weak glp-1(gf) allele, whereas those that act solely in meiotic progression should not enhance. glp-1(ar202gf) is a temperature sensitive allele that at the restrictive temperature, displays a Pro phenotype and a lateonset-tumorous phenotype (Pepper et al., 2003a,b) where the size of the distal proliferative zone increases over time. At the permissive temperature (15jC), however, neither of these mutant phenotypes is observed. We found that each of three double mutant combinations of glp-1(ar202gf) with nos-3, gld-1, or gld-2 enhances the late-onset tumorous phenotype of glp-1(ar202gf) at the permissive temperature (Fig. 6) , suggesting that nos-3, gld-1, and gld-2 are involved in the proliferation versus meiotic entry decision. Therefore, the meiotic cells that are observed in these synthetic tumorous mutants are likely due to an incomplete inhibition of meiotic entry rather than normal meiotic entry followed by reversion to mitosis.
A third pathway promotes initiation of meiotic development in late larvae/adults and is negatively regulated by GLP-1-mediated signaling To further understand the processes controlling meiotic entry, we examined the temporal and spatial pattern of meiotic entry during development in the synthetic tumorous mutants. For this analysis, we examined the pattern of REC-8 and HIM-3 staining in synchronous populations of staged animals at 6-h intervals throughout development (Fig. 7) . In synthetic tumorous animals, germ cells entered meiosis later in development as compared to control animals (Fig. 7) . Indeed, all wild-type control animals display REC-8-nega- e Actual genotype is dpy-19(e1259) unc-32(e189) glp-1(oz112gf)/dpy-19(e1259) unc-32(e189) glp-1(oz112gf); qDp3 (qDp3 contains unc-32(e189) and wild-type copies of dpy-19 and glp-1) grown at 25jC. f Actual genotype; gld-2(q497) gld-1(q485); unc-32(e189). g Actual genotype; gld-2(q497); nos-3(oz231); unc-32(e189); however, similar results were obtained with an unmarked strain. h Actual genotype; gld-2(q497) gld-1(q485); nos-3(oz231); unc-32(e189). i Actual genotype; gld-2(q497) gld-1(q361); unc-32(e189). j Actual genotype; gld-2(q497) gld-1(q485); unc-32(e189) glp-1(q175). k Actual genotype; gld-2(q497); nos-3(oz231); unc-32(e189) glp-1(q175). l Actual genotype; gld-2(q497) gld-1(q485); unc-32(e189) glp-1(ar202). Substantial meiotic entry is normally observed in unc-32(e189) glp-1(ar202) double mutants at 20jC (Pepper et al., 2003a) .
tive/HIM-3-positive cells by 38 h past L1 arrest, whereas REC-8-negative/HIM-3-positive cells are not visible until 56 h in gld-2(q497) gld-1(q485) gonads and until 44 h in gld-2(q497); nos-3(oz231) animals. Furthermore, when meiotic entry occurs in the tumorous mutants, it occurs at a greater distance from the distal end than in wild type (Figs. 7A, B, and C). Therefore, early in development removal of the activities of GLD-1 and GLD-2 (or NOS-3 and GLD-2) appears equivalent to constitutive activation of the GLP-1 receptor (glp-1(oz112gf)/glp-1(oz112gf)/glp-1(+)), in that germ cells fail to enter meiosis. However, later in development, unlike the glp-1(gf) tumor, the synthetic tumors show meiotic entry. This suggests that later in development, glp-1 negatively regulates at least one additional pathway that promotes meiotic entry, in addition to the gld-1 and gld-2 pathways. If a putative third pathway functions downstream of GLP-1/Notch signaling, then elevating the activity of the glp-1 pathway in gld-2 gld-1 animals should reduce the extent of meiotic entry. Conversely, if only the gld-1 and gld-2 pathways, and not a third pathway, are regulated by GLP-1/Notch signaling, then elevating the activity of GLP-1 should not affect the number of cells entering meiosis in a gld-2 gld-1 tumor. We examined the extent of meiotic entry in gld-2 gld-1; glp-1(ar202gf) triple mutant animals and found no evidence of meiotic entry (Table 1) . These results suggest that a third pathway acts in opposition to and downstream of the GLP-1/Notch signaling pathway to allow meiotic entry to occur.
We also examined the extent of meiotic entry in the synthetic tumorous mutants in the absence of glp-1. We reasoned that although the gld-2 gld-1 synthetic tumorous phenotype is epistatic to the glp-1(lf) phenotype, the removal of glp-1 might result in a qualitatively less tumorous phenotype (that is, more REC-8-negative/HIM-3-positive cells or more cells in meiosis) than the synthetic tumorous phenotype in an otherwise glp-1(+) background. Surprisingly, removal of GLP-1 activity from synthetic tumorous mutants in the triple mutants gld-2(q497) gld-1(q485); glp-1(q175) and gld-2(q497); nos-3(oz231); glp-1(q175) results in gonads with fewer cells exhibiting meiotic entry than when the GLP-1/Notch pathway is active (Fig. 7, Table 1) . Furthermore, the meiotic entry that does occur in these triple mutants occurs later in development than when the GLP-1 activity is present (Fig. 7, Table 1 ). One explanation for these counterintuitive results is that when GLP-1/Notch signaling is removed, germ cells enter meiosis much earlier in development and return to proliferation before the time of our analysis. To examine this possibility, we analyzed dissected gld-2(q497) gld-1(q485); glp-1(q175) gonads at Actual genotypes are glp-1(ar202gf), gld-1(q485), gld-2(q497), and nos-3(oz231). All strains were also marked with unc-32(e189) and grown at 15jC. For each strain, the mitotic zones of at least 15 gonad arms were measured. For each of gld-1, gld-2, and nos-3, when in combination with glp-1(ar202gf), the region containing REC-8-positive/HIM-3-negative cells (proliferative zone) was larger and the meiotic entry region displaced proximally as compared to the single mutants. For single mutants versus relative double mutants, P < 6. two earlier time points, 26 and 32 h past L1 arrest (late L2/ early L3), and all germ cells were proliferative (REC-8-positive HIM-3-negative). The average number of germ cells per animal (not arm) at 26 h was 12.6 (n = 15, range 10 -16). Meiotic entry likely would not have occurred before this time because both gld-1; glp-1 and gld-2; glp-1 double mutant animals produce a total of approximately 32 cells per animal (Francis et al., 1995b; Kadyk and Kimble, 1998) . Therefore, the reduced of amount of meiotic entry in synthetic tumorous mutants when GLP-1 activity is removed is not likely due to germ cells entering meiosis earlier in development, but rather could reflect a role for GLP-1 in inhibiting proliferation and/or promoting meiotic entry (see Discussion).
In the course of conducting these experiments, we found that the gld-2 gld-1 double mutant with gld-1(q361) displayed fewer cells undergoing meiotic entry (that is, the tumorous phenotype was more proliferative) than when the gld-1 null allele was used (Table 1 ). The gld-1(q361) missense mutation prevents the GLD-1 protein product from binding target mRNAs, but allows production of the nonfunctional protein at essentially wild-type levels (Jan et al., 1999; Jones and Schedl, 1995; Jones et al., 1996; Lee and Schedl, 2001) . gld-1(q361) behaves as a genetic null for GLD-1's essential function in female germ cell meiotic prophase progression and has some dominant negative properties relative to male sex determination (more heterozygous feminized animals are seen than with the null Francis et al., 1995a) . This enhanced tumorous phenotype suggests that the GLD-1(q361) protein could bind to and interfere with the normal activity of proteins that would otherwise promote meiotic entry and/or inhibit proliferation. The factor(s) that the GLD-1(q361) protein is poisoning could normally function in the putative third pathway regulating meiotic entry. Fig. 7 . Synthetic tumorous mutants enter meiosis later in development. Graphs showing the extent of meiotic entry at various points in development in synthetic tumorous mutants with the numbers of cell diameters from the DTC on the y axes and number of hours past L1 arrest on the x axes. Meiotic entry was measured by determining the position from the DTC of REC-8 and HIM-3 staining cells. Actual genotypes (A) unc-32(e189) (B) gld-2(q497) gld-1(q485); unc-32(e189) (C) gld-2(q497); nos-3(oz231); unc-32(e189) (D) gld-2(q497) gld-1(q485); unc-32(e189) glp-1(q175) (E) gld-2(q497); nos-3(oz231); unc-32(e189) glp-1(q175). For all time points, the region containing meiotic cells is defined as the region from the most distal REC-8-negative HIM-3-positive cell to the most proximal REC-8-negative HIM-3-positive cell even though some cells between these two boundaries could be REC-8-positive HIM-3-negative. For most time points, 10 gonad arms where analyzed with 5 gonad arms for one time point (gld-2; nos-3; unc-32 glp-1 at 38 h). For the 62-h time point in unc-32 animals, no maximum distance was measured because these animals contained sperm in the proximal end of the gonad making the cell diameter measurement of distance from the distal end inaccurate. Error bars = 1 SD.
We also found that gld-2(q497) gld-1(q485); nos-3(oz231) triple mutants have fewer germ cells enter meiosis than in either gld-2(q497) gld-1(q485) or gld-2(q497); nos-3(oz231) double mutants (Table 1) . Previous data indicate that NOS-3 functions to promote GLD-1 accumulation in the GLD-1 pathway (Hansen et al., 2004) . These current results further suggest that NOS-3 may regulate a meiosispromoting factor that is distinct from the GLD-1 and GLD-2 pathways.
Discussion
REC-8 and HIM-3 antibodies as tools for investigating meiotic entry
The initiation of meiosis is a key step in germline development and must be tightly regulated to ensure reproductive fitness. We have characterized the temporal and spatial properties of meiotic entry in the C. elegans germline using antibodies that specifically distinguish proliferative and meiotic germline cells. The current model of meiotic entry proposes that germ cells close to the DTC have elevated GLP-1 signaling, which inhibits the GLD-1 and GLD-2 pathways, while germ cells further away from the DTC have low levels of GLP-1 signaling, allowing for activation of the GLD-1 and GLD-2 pathways and meiotic entry ensues. We have used antibodies that recognize REC-8 (Pasierbek et al., 2001 ) and HIM-3 (Zetka et al., 1999) to study the initiation of meiotic development. REC-8 is in the nucleoplasm and on the chromosomes during proliferation and then localizes to the proteinacious core of sister chromatids in meiotic prophase. Under our fixation conditions, only the nucleoplasmic and non-proteinacious core chromosomal REC-8 localization is observed. The appearance of HIM-3 on chromosomes, during meiotic prophase, corresponds to the loading of HIM-3 onto chromosomal axes (Zetka et al., 1999) . The first overt event in meiotic development is DNA replication (Forsburg, 2002 ). It appears to be distinct from mitotic S phase and is important for inter-homolog recombination. It is also important for chromosome segregation in the MI and MII divisions, which is, at least in part, a consequence of loading the meiotic cohesion REC-8 onto chromosomes during meiotic S phase (Forsburg, 2002) . It is likely that conversion from REC-8 staining to HIM-3 staining is a consequence of meiotic S phase or its completion.
Spatial control of meiotic entry
Our analysis of the border of proliferation and meiotic prophase using REC-8 and HIM-3 antibodies reveals a developmental change in the proliferation versus meiotic prophase decision. In early larval germlines, in which meiotic prophase has begun but the distal proliferative zone is still growing, cells switch from proliferation to meiosis as they cross a distance of one germ cell diameter. In contrast, the switch from proliferation to meiotic prophase in late L4/ adulthood occurs, on average, over a region of seven cell diameters in length (from 19 to 26 cell diameters from the distal tip; the meiotic entry region, Figs. 2 and 3 ). The temporal difference in the sharpness of the proliferation versus meiotic entry boundary may be a reflection of differences in the regulation of meiotic entry during development. Alternatively (or additionally), this temporal difference may have to do with there being significantly fewer germ cells in early larval gonads and that these cells are larger than in later stages.
Although the distal proliferation zone in the adult C. elegans germline is a stem cell population in the sense that it is both self-renewing and produces cells that differentiate, it is currently unknown whether all cells in this zone are stem cells. While cells undergoing mitotic divisions are observed throughout this zone, it is formally possible that only the cells closest to the DTC are stem cells and that they undergo transit amplification before entering pre-meiotic S phase. This situation would be analogous to gonialblast proliferation in the Drosophila germline (Kiger and Fuller, 2001; Xie and Spradling, 2001 ). Most of the surface area of the DTC spreads over several cell diameters of the germline, and on average, DTC processes extend only as far as the distal-half of the proliferative zone (Hall et al., 1999) , though processes can extend to the edge of the proliferative zone (Fitzgerald and Greenwald, 1995) . Therefore, cells in the proximal portion of the proliferative zone may come in contact with a significantly lower level of LAG-2 ligand than those in the distal portion, and cells could commit to enter meiotic prophase more distally than anti-REC-8 and anti-HIM-3 antibodies reveal. Alternatively, the region between the majority of DTC-bound LAG-2 ligand and meiotic entry could reflect a slow decay rate of GLP-1/Notch signaling [e.g., the half life of nuclear GLP-1(INTRA)]. A developmental analysis of the dynamics of cell division compared to signaling levels in the distal proliferative zone will be of significant interest, although this analysis is currently not feasible since there is no available method to monitor nuclear GLP-1(INTRA).
It is also important to note that GLD-1, which promotes meiotic entry, reaches a high level of accumulation distal to some cells that appear not to have entered meiosis. GLD-1 levels are low in the distal end, then increase until reaching a high level approximately 20 cell diameters from the distal end (Hansen et al., 2004; Jones et al., 1996) . It is currently unknown what level of GLD-1 is necessary to promote meiotic entry, although the fact that not all cells have entered meiosis when GLD-1 levels are high would suggest that either cells commit to enter meiosis while still REC-8-positive/HIM-3-negative (distal to the meiotic entry region), or that cells differ in their competence to respond to meiotic entry signals.
What could account for the nonuniform entry into meiotic prophase in the late larval/adult germline? One possible contributing factor could be that the mitotic cell cycle within the proliferation zone is asynchronous. Previous studies of the wild-type proliferative zone showed that cells in mitotic M-phase are infrequent and relatively randomly scattered. Cells at a given distance from the distal tip appear to be at various stages of the cell cycle (Crittenden et al., 1994; Francis et al., 1995a; Kadyk and Kimble, 1998; Kuwabara et al., 2000) . This result is not expected given the syncitial nature of the germline. For example, in the Drosophila syncytial blastoderm embryo, there is a very high degree of cell cycle synchrony (Foe and Alberts, 1983) . This difference has led to the proposal that while the distal C. elegans germline is syncytial, each germline nucleus, cytoplasm, and surrounding membranes (called a germ cell) acts as an autonomous unit with respect to mitotic cell cycle progression, and that diffusion of cell cycle control factors is limited. If, for example, the switch from proliferation to meiotic development can only be made in G1, then the nonuniform or staggered initiation of meiotic development may be a consequence of cells, at various stages of the mitotic cell cycle, entering a critical region of the gonad where signaling is sufficient to promote entry into meiotic prophase. Therefore, some cells must progress to G1 (moving more proximally as they do so) before entering meiotic prophase, while other cells that are in G1 as they enter the critical region can immediately enter meiotic prophase. It is also possible that if there are transit amplifying cycles in the proliferative germline (see above), the number or length of the cell cycles could differ between cells, thereby causing cells to enter meiotic prophase at different positions in the gonad.
Another related mechanism that may account for the staggered border between proliferation and meiotic prophase in late L4/adults could be cell autonomous differences in the levels of GLP-1 signaling-either stochastic differences in the half-life of nuclear GLP-1(INTRA), differences in contact with LAG-2 due to the nonuniform shape of the DTC (Hall et al., 1999) , or some other differences in signaling. A caveat to this model is that GLD-1 accumulation, our only available molecular read-out of GLP-1 signaling in the germline (Hansen et al., 2004) , appears to be uniform between cells at a given distance from the distal end in the adult (Jones et al., 1996) . However, since GLD-1 accumulation is cytoplasmic, and germ cells are not completely separate, some diffusion of GLD-1 may occur between germ cells. Indeed, this diffusion may be a means of leveling differences in GLP-1 signaling between adjacent cells, thereby reducing the potential amount of nonuniform meiotic entry.
Evidence for additional pathway/pathways regulating the adult proliferation versus meiotic entry decision
We have shown that constitutive activation of GLP-1 results in a homogenously proliferative tumor of REC-8-positive/HIM-3-negative cells, likely due to a failure of cells to enter meiotic prophase. However, we cannot completely rule out the possibility that some cells in these tumors briefly enter meiosis but do not progress far enough into meiotic prophase to be detected by these markers. Nevertheless, these markers do show that the tumors resulting from inactivation of the downstream GLD-1 and GLD-2 pathways contain significant numbers of cells in the early stages of meiosis (Fig. 4, Table 1 ). If prevention of meiotic entry via GLP-1/Notch signaling were acting through the gld-1 and gld-2 pathways alone, then eliminating these two pathways should be phenotypically equivalent to constitutive activation of glp-1. The presence of meiotic cells in gld-2 gld-1 and gld-2; nos-3 tumors are either due to a defect in meiotic progression (analogous to the gld-1 single mutant; Francis et al., 1995a) , or that there is a third (at least) pathway downstream of GLP-1/Notch signaling regulating meiotic entry. Our genetic results demonstrating enhancement of a weak glp-1(gf) allele by mutations in gld-1, gld-2, or nos-3, and results of our time course analysis, support a role for GLD-1, GLD-2, and NOS-3 in the meiotic entry decision. Taken together, these results implicate a third pathway promoting meiotic entry and/or inhibiting proliferation, acting downstream of GLP-1/Notch signaling and parallel with the GLD-1 and GLD-2 pathways.
The relative strength of the putative third pathway is apparently lower than that of the gld-1 or gld-2 pathways. Even though some meiotic entry occurs in a gld-2 gld-1 tumor, most of the germ cells are proliferative and the tumor is epistatic to the glp-1(null) premature meiotic entry phenotype. Additionally, the reliance on this third pathway appears to be lower or absent in hermaphrodite larvae relative to adults because meiotic entry in the synthetic tumorous mutants is delayed relative to meiotic entry in wild type.
While no components of the putative third pathway have yet been identified, our data provide some clues that may assist in their identification. It is possible that a component of the third pathway binds to the GLD-1 protein since fewer cells enter meiosis in gld-2(q497) gld-1(q361) than in gld-2(q497) gld-1(q485null) gonads. The phenotype of gld-1(q361) single mutant is very similar to that of the gld-1 null; however, it produces protein at equivalent levels to wild-type that is unable to bind at least some of its target mRNAs (Jan et al., 1999; Jones et al., 1996; Lee and Schedl, 2001) . Thus, the nonfunctional GLD-1(q361) protein may bind a component of the third pathway and prevent it from performing its normal function. Additionally, NOS-3 may be involved in regulating the activity of a component of the third pathway. First, gld-2 gld-1; nos-3 hermaphrodite germlines contain fewer meiotic cells than either gld-2 gld-1 or gld-2; nos-3 double mutants indicating a function in meiotic entry independent of the gld-1 or gld-2 pathways. Second, many gld-1(q485);nos-3(oz231) males have a synthetic proximal proliferation phenotype (Hansen et al., 2004) , which is presumably due to a failure of some proximal germ cells to enter meiosis. At a minimum, this demonstrates that NOS-3 is performing a function in regulating meiotic entry in addition to its role in promoting GLD-1 accumulation (Hansen et al., 2004) . Further, we propose that the third pathway is unable to compensate for the loss of GLD-1 and GLD-2 in younger hermaphrodites. It is not until gld-2(q497) gld-1(q485) hermaphrodites are older that meiotic cells are seen. This could mean that the third pathway only functions in late larvae/adult hermaphrodites (Fig. 8) , or that a single pathway is not sufficient to cause meiotic entry in younger hermaphrodites, but is sufficient in adults. These data are consistent with previous results (Berry et al., 1997; Pepper et al., 2003b) suggesting that some differences exist between the control of meiotic entry during different stages of development.
The effect of GLP-1(+) on synthetic tumorous mutants Our analysis uncovered a paradox in the role of glp-1 in the proliferation versus meiotic development decision. A wealth of data support the conclusion that the role of glp-1(+) is to promote proliferation and/or inhibit meiotic entry (Austin and Kimble, 1987; Berry et al., 1997; Lambie and Kimble, 1991; Pepper et al., 2003a) . Our observation that gld-2 gld-1; glp-1(ar202gf) animals are completely tumorous (that is, contain only proliferating cells; Table 1 ) also supports this role for glp-1. Our unexpected result is that genetic removal of glp-1, using the null allele glp-1(q175), reduced the number of meiotic cells in gld-2 gld-1 and gld-2; nos-3 synthetic tumors. A possible model explaining this result is that glp-1 could function in both promoting and inhibiting proliferation (and/or inhibiting and promoting meiotic development) (Fig. 8) . For example, the proposed third pathway could require GLP-1 activity in order for it to promote meiotic entry and/or inhibit proliferation.
Another possible, perhaps more likely, explanation for this apparent paradox can best be understood in the context of a proposed positive feedback mechanism between proliferation or active GLP-1 signaling and GLP-1 protein expression and/or activity (Berry et al., 1997; Kadyk and Kimble, 1998; Kodoyianni et al., 1992) . gld-2 gld-1 synthetic tumorous mutants (in the presence of wild-type GLP-1) have excess membrane-associated GLP-1 (Kadyk and Kimble, 1998) . This excess GLP-1, which is distant from the LAG-2 ligand and therefore is unlikely to produce GLP-1(INTRA) and activate signaling, could bind and titrate proliferation-promoting or meiosis-inhibiting factors. In tumorous animals that do not make GLP-1 protein (e.g., gld-2 gld-1; glp-1), the titration of these factors would not occur and fewer cells would enter meiosis. glp-1(oz112gf) animals, which also have GLP-1 on membranes throughout the germline, do not show titration-associated meiotic entry, possibly because the ectopically expressed GLP-1 is constitutively active, presumably continually generating GLP-1(INTRA), which would inhibit downstream pathways throughout the germline.
Even though the positive feedback regulation of GLP-1 could be involved in the extent of meiotic entry in synthetic tumorous mutants, it likely does not play a role in regulating meiotic entry in wild-type adults. Recent work indicates that a GLP-1 positive feedback mechanism could be accomplished through GLD-1 (Marin and Evans, 2003) . GLD-1 binds the GLP-1 3VUTR and represses its translation. In the part of the germline closest to the DTC, GLP-1 signaling is high and represses GLD-1 accumulation (Hansen et al., 2004) . More proximally, further away from the DTC-bound LAG-2 ligand, GLP-1 signaling is reduced, allowing for increased expression of GLD-1, which then can bind to the 3VUTR of GLP-1, inhibiting its translation. This inhibition of GLP-1 translation is not necessary for the proliferation versus meiotic entry decision because in gld-1(null) animals, where no GLD-1-mediated translational inhibition of glp-1 can occur, germ cells enter meiosis at approximately the normal position ( Fig. 6 ; Francis et al., 1995a) , even though excess GLP-1 is produced (Marin and Evans, 2003) . Also, high levels of GLP-1 and GLD-1 coexist at approximately 20 cell diameters from the DTC, and little LAG-2 ligand is likely present at this distance from the DTC (Hall Fig. 8 . Model depicting genetic interaction regulating meiotic entry in L3/ L4 versus adult hermaphrodites. (A) In L3/L4 hermaphrodites, GLP-1/ Notch signaling inhibits the GLD-1 and GLD-2 pathways in the distal end of the gonad, but as cells move proximally, these pathways become active causing meiotic entry to occur. When the activities of these pathways are eliminated through genetic mutation, germ cells fail to enter meiotic prophase forming a homogenous tumor of proliferating cells. (B) In adult hermaphrodites, elimination of GLD-1 and GLD-2 pathways is not sufficient to completely prevent meiotic entry, suggesting that a third pathway (X) may still be promoting meiotic development and/or inhibiting proliferation. Therefore, in the wild-type adult hermaphrodite germline, all three pathways may be regulating the proliferation versus meiotic entry decision. The relative importance of each pathway may vary depending on age, sex, and environmental conditions. It is further possible that the third pathway requires GLP-1 activity to function properly. Henderson et al., 1994) , making it unlikely that GLD-1 repression of GLP-1 translation is important for meiotic entry in the distal germline. Rather, this feedback loop is more likely part of the mechanism to prevent GLP-1 from being expressed in the proximal germline and interfering with GLP-1 function in the early embryo, as previously suggested (Kadyk and Kimble, 1998) .
Why do multiple redundant pathways control meiotic entry?
One proposed purpose of redundancy is to increase the fidelity of the regulated process (Thomas, 1993) . The proliferation versus meiotic entry decision requires a tight balance: too much proliferation (too little meiotic entry) results in a germline tumor, and too little proliferation (too much meiotic entry) causes a depletion of the stem cell population. Either result causes sterility or a reduction in reproductive fitness. The reproductive fitness of a species is central to its survival and would likely have enormous evolutionary pressure pushing toward maximizing efficiency. GLD-1 is a KH domain translational inhibitor (Jan et al., 1999; Jones and Schedl, 1995; Lee and Schedl, 2001) , while GLD-2 is the catalytic portion of a poly(A) polymerase (Wang et al., 2002) ; therefore, redundancy between these two pathways cannot simply be explained by the two proteins performing similar compensatory biochemical functions. Perhaps in this case, the GLD-1, GLD-2, and putative third pathways allow several different control points (and the importance of each point may differ depending on age, sex, or environmental condition), resulting in an overall more robust system and the maintenance of a perfect balance.
